Another study identified that B cell receptor-associated protein 31 (BAP31) can promote tumor cell proliferation by stabilizing serine protease inhibitor clade E member 2 (SERPINE2), making it a potential therapeutic target for HCC [52] (Fig. 3a). This evidence concerns the gene BCAP31 and hepatocellular carcinoma.